- Home
- KIM vs SNN Comparison
KIM vs SNN Comparison
Compare KIM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIM
- SNN
- Stock Information
- Founded
- KIM 1958
- SNN 1856
- Country
- KIM United States
- SNN United Kingdom
- Employees
- KIM N/A
- SNN N/A
- Industry
- KIM Real Estate Investment Trusts
- SNN Industrial Specialties
- Sector
- KIM Real Estate
- SNN Health Care
- Exchange
- KIM Nasdaq
- SNN Nasdaq
- Market Cap
- KIM 14.4B
- SNN 12.3B
- IPO Year
- KIM 1991
- SNN 1999
- Fundamental
- Price
- KIM $20.92
- SNN $28.05
- Analyst Decision
- KIM Buy
- SNN Hold
- Analyst Count
- KIM 16
- SNN 3
- Target Price
- KIM $24.28
- SNN $27.00
- AVG Volume (30 Days)
- KIM 5.6M
- SNN 744.3K
- Earning Date
- KIM 05-01-2025
- SNN 02-25-2025
- Dividend Yield
- KIM 4.78%
- SNN 2.62%
- EPS Growth
- KIM N/A
- SNN 56.15
- EPS
- KIM 0.55
- SNN 0.47
- Revenue
- KIM $2,037,014,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- KIM $4.56
- SNN $6.42
- Revenue Next Year
- KIM $3.24
- SNN $5.03
- P/E Ratio
- KIM $38.04
- SNN $29.40
- Revenue Growth
- KIM 14.22
- SNN 4.70
- 52 Week Low
- KIM $17.57
- SNN $23.65
- 52 Week High
- KIM $25.83
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- KIM 43.73
- SNN 48.82
- Support Level
- KIM $20.46
- SNN $27.83
- Resistance Level
- KIM $21.50
- SNN $28.71
- Average True Range (ATR)
- KIM 0.53
- SNN 0.43
- MACD
- KIM 0.06
- SNN -0.21
- Stochastic Oscillator
- KIM 61.00
- SNN 10.14
About KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 569 shopping centers throughout major markets in the US, representing roughly 87 million square feet.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.